CNS Pharmaceuticals, Inc. (CNSP) › Cash & EquivalentsCNS Pharmaceuticals, Inc. (CNSP) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $282.7K2019: $7.24M2020: $14.04M2021: $5.00M2022: $10.06M2023: $548.7K2024: $6.46M2025: $7.20M$7.20M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$7.20M+11.4%2024$6.46M+1077.5%2023$548.7K-94.5%2022$10.06M+100.9%2021$5.00M-64.4%2020$14.04M+93.9%2019$7.24M+2461.1%2018$282.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share